Smith & Nephew plc (LON:SN) traded up 5.7% during trading on Thursday . The stock traded as high as GBX 1,547.50 ($20.22) and last traded at GBX 1,545 ($20.19). 3,302,420 shares traded hands during trading, an increase of 2% from the average session volume of 3,250,000 shares. The stock had previously closed at GBX 1,461.50 ($19.10).
Several research analysts have issued reports on the stock. Deutsche Bank raised shares of Smith & Nephew to a “hold” rating and raised their price objective for the stock from GBX 1,200 ($15.68) to GBX 1,350 ($17.64) in a research report on Monday, December 10th. Morgan Stanley raised shares of Smith & Nephew to an “overweight” rating and raised their price objective for the stock from GBX 1,457 ($19.04) to GBX 1,692 ($22.11) in a research report on Monday, December 10th. JPMorgan Chase & Co. downgraded shares of Smith & Nephew to a “neutral” rating and set a GBX 1,477 ($19.30) price objective on the stock. in a research report on Wednesday, January 2nd. UBS Group raised their price objective on shares of Smith & Nephew from GBX 1,340 ($17.51) to GBX 1,390 ($18.16) and gave the stock a “neutral” rating in a research report on Monday, January 28th. Finally, Berenberg Bank raised their price objective on shares of Smith & Nephew from GBX 1,370 ($17.90) to GBX 1,475 ($19.27) and gave the stock a “hold” rating in a research report on Friday, November 2nd. Seven analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of GBX 1,463.22 ($19.12).
ILLEGAL ACTIVITY NOTICE: This story was originally posted by Markets Daily and is owned by of Markets Daily. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.themarketsdaily.com/2019/02/07/smith-nephew-sn-trading-5-7-higher.html.
About Smith & Nephew (LON:SN)
Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Featured Story: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.